I've been hoping Progenity would consolidate after an overheated run up to $4+ this quarter and I finally got my wish. As predicted with a 'Meh' earnings it's had its violent swing but it's been holding the 50 EMA on an intraday basis and if that can continue it might be a good play for additional swings. As far as fundamentals go: Look it's a biotech company. You know the drill.
A potential downtrend is still in the cards as the entire market is overheated and we need a double digit correction in general imo so I won't be going long without a good reason. If this stock follows the market you're looking at a hypothetical test of the 200 EMA at least at $2.46.
Regardless, if you wanna risk it there is an earnings gap freakout (an overreaction in my opinion) that will probably be filled in the next week. Do what thou wilt.